Sutro Biopharma Reports Third Quarter 2024 Financial Results and ...

Total operating expenses for the quarter ended September 30, 2024 were $76.4 million, as compared to $60.9 million for the same period in 2023.

Sutro Biopharma Third Quarter 2024 Earnings - Yahoo Finance

Sutro Biopharma ( NASDAQ:STRO ) Third Quarter 2024 Results Key Financial Results Revenue: US$8.52m (down 50% from 3Q...

Sutro Biopharma Reports Third Quarter 2024 Financial

Sutro Biopharma Reports Third Quarter 2024 Financial Results and Business Highlights ; Non-cash interest expense related to the sale of future ...

Sutro Biopharma, Inc. (STRO)

Nov 13, 2024 4:30 pm EST. Sutro Biopharma Reports Third Quarter 2024 Financial Results and Business Highlights View Press Release. Nov 4, 2024 4:05 pm EST.

Sutro Biopharma Reports Third Quarter 2024 Financial Results and ...

Sutro Biopharma Reports Third Quarter 2024 Financial Results and Business Highlights · Strong cash position of $388.3 million · 56% response rate ...

Sutro Biopharma Reports Third Quarter 2024 Financial Results And ...

Sutro reported having $388.3 million in cash and marketable securities as of September 30, 2024, and is seeking a partner to aid in the multi- ...

Sutro Biopharma, Inc. Reports Earnings Results for the Third Quarter ...

Sutro Biopharma, Inc. reported earnings results for the third quarter and nine months ended September 30, 2024. For the third quarter, ...

Sutro Biopharma, Inc. (STRO) Reports Q3 Loss, Misses Revenue ...

(STRO) came out with a quarterly loss of $0.59 per share versus the Zacks Consensus Estimate of a loss of $0.74. This compares to loss of $0.81 ...

Sutro Biopharma, Inc. is a public biotechnology company focused on ...

Sutro Biopharma Reports Third Quarter 2024 Financial Results and Business Highlights – Expects to deliver three Investigational New Drug (IND) applications in ...

Financial Results - Sutro Biopharma, Inc.

Financial Info. Overview · Financial Results · Income Statement · Balance Sheet · Cash Flow. 2024. Q2 2024. Quarter Ended Jun 30, 2024. Earnings Release HTML ...

News | Sutro Biopharma, Inc.

Sutro Biopharma Reports Third Quarter 2024 Financial Results and Business Highlights. Nov 13, 2024. - Expects to deliver three Investigational New Drug (IND) ...

Health Stocks News on X: "Sutro Biopharma Reports Third Quarter ...

Sutro Biopharma Reports Third Quarter 2024 Financial Results and Business Highlights $STRO https://t.co/HgkdMkV1G2.

Business Highlights and Select Anticipated Milestones

Sutro Biopharma Reports First Quarter 2024 Financial Results, Business Highlights and Select Anticipated Milestones – Investigational New Drug application for ...

Sutro Biopharma Inc (STRO) Q3 2024 Earnings: Revenue Misses Esti

Quarterly Financial Performance ... Sutro Biopharma Inc reported a revenue of $8.5 million for the third quarter of 2024, falling short of the ...

Sutro Biopharma Reports Third Quarter 2024 Financial Results and ...

Expects to deliver three Investigational New Drug (IND) applications in next three years based on next-generation ADC technology - - Two new clinical trials ...

Vaxcyte Reports Third Quarter 2024 Financial Results and Provides ...

“On the heels of our positive VAX-31 data, we completed a follow-on equity offering, raising $1.4 billion in net proceeds and further bolstering our balance ...

Day One Reports Third Quarter 2024 Financial Results and ...

Strong growth in OJEMDA net revenue with $20.1M in the third quarter of 2024, representing a 145% increase over the second quarter of 2024. Quarterly ...

Sutro Biopharma Beat Consensus Estimates - Earnings Whispers

Sutro Biopharma (STRO) reported a loss of $0.59 per share on revenue of $25.71 million for the second quarter ended June 2024. The consensus estimate was a loss ...

EX-99.1 - SEC.gov

Exhibit 99.1. Sutro Biopharma Reports First Quarter 2024 Financial Results, Business Highlights and Select Anticipated Milestones.

Sutro Biopharma Reports Third Quarter 2024 Financial Results and ...

Sutro Biopharma Reports Third Quarter 2024 Financial Results and Business Highlights · Comments Section · Community Info Section · More posts you ...